Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals.
about
CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigensCell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression.The early activation of CD8+ T cells is dependent on type I IFN signaling following intramuscular vaccination of adenovirus vector.HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses.Aflatoxin-related immune dysfunction in health and in human immunodeficiency virus diseaseBiomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.A whole-blood assay for qualitative and semiquantitative measurements of CD69 surface expression on CD4 and CD8 T lymphocytes using flow cytometry.CD69 expression reliably predicts the anti-CD3-induced proliferative response of lymphocytes from human immunodeficiency virus type 1-infected patients.Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.Expression of CD69 on T-cell subsets in HIV-1 disease.Expression of the activation antigen CD69 predicts functionality of in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients.Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy.The effects of Phyllanthus niruri aqueous extract on the activation of murine lymphocytes and bone marrow-derived macrophages.
P2860
Q33593498-F1E4BD17-077D-437E-BAF0-EB7F39DF7D27Q33652869-3A10C649-79B8-4BF2-B18E-40DE0E5840C5Q33757762-58FBD108-A379-480E-99E8-55FE63F96043Q36167859-FA225A58-A806-4A5B-B6C3-29633A6948E8Q36812714-FB3A4113-1238-4E3E-B888-46684208C9ADQ37862747-E92CF3F9-0782-4C83-B791-E1598B11B82AQ39552186-CE5764CB-D144-49A2-A4BF-229D24E1385BQ39811159-8D0B799F-DEFA-478A-B7D7-2C1FB460F502Q41885967-F6613A38-84B8-4960-BB43-DB04B2A04A27Q43516931-24A1C85F-43D8-4837-B878-915578A69072Q45889509-C59F2421-FFCE-49CD-BC0A-F1EB5E5959B6Q50044364-C3D00A38-593A-4FB9-98B2-08CCEF27A2A0Q50604050-BC0EE368-6466-4492-9486-FDEF5542214B
P2860
Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@ast
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@en
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@nl
type
label
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@ast
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@en
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@nl
prefLabel
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@ast
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@en
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@nl
P2093
P1476
Expression of CD69 after in vi ...... s in HIV-infected individuals.
@en
P2093
P304
P356
10.1097/00042560-199601010-00013
P407
P577
1996-01-01T00:00:00Z